Fuchs Henry J

Fuchs Henry J is listed in filings as President at Biomarin Pharmaceutical Inc. This profile follows SEC Form 4 activity through Sep 17, 2024, including 1 public disclosure. Recent filings connect the profile to Biomarin Pharmaceutical Inc (BMRN). The current snapshot covers public activity from Sep 17, 2024. Reported amounts are shown as $1.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.